Weybosset Research & Management’s Biohaven BHVN Stock Holding History

Weybosset Research & Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$298K	Sell	20,000 -2,990	-13%	-$32.2K	0.08%	30
2026 Q1	$194K	Hold	22,990	–	–	0.06%	33
2025 Q4	$260K	Buy	22,990 +50	+0.2%	+$619	0.08%	34
2025 Q3	$344K	Buy	22,940 +3,660	+19%	+$53.3K	0.11%	30
2025 Q2	$272K	Buy	19,280 +2,400	+14%	+$42.8K	0.09%	32
2025 Q1	$406K	Buy	16,880 +3,235	+24%	+$114K	0.14%	28
2024 Q4	$510K	Buy	13,645 +2,635	+24%	+$123K	0.17%	29
2024 Q3	$550K	Hold	11,010	–	–	0.19%	29
2024 Q2	$382K	Sell	11,010 -2,630	-19%	-$104K	0.14%	30
2024 Q1	$5.08M	Hold	13,640	–	–	1.77%	20
2023 Q4	$584K	Buy	13,640 +1,500	+12%	+$46.6K	0.21%	28
2023 Q3	$316K	Buy	12,140 +2,000	+20%	+$41.6K	0.13%	31
2023 Q2	$243K	Buy	+10,140	New	+$175K	0.09%	33

Other funds holding BHVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Weybosset Research & Management's BHVN Position: Q2 2026 in Review

Weybosset Research & Management reduced its Biohaven (BHVN) stake by 13% in Q2 2026, selling an estimated $32.2K and leaving 20,000 shares worth $298K. The position accounts for 0.08% of the portfolio, ranked #30.

Weybosset Research & Management first reported a position in BHVN in Q2 2023 and has held it in 13 quarters since. The position peaked at $5.08M in Q1 2024. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

Weybosset Research & Management held 20,000 shares of Biohaven worth $298K as of Q2 2026.
Weybosset Research & Management sold 2,990 Biohaven shares in Q2 2026, an estimated $32.2K.
Biohaven made up 0.08% of Weybosset Research & Management's portfolio in Q2 2026, its #30 holding.
Weybosset Research & Management first reported a position in Biohaven in Q2 2023 and has held it in 13 quarters since.
Weybosset Research & Management's Biohaven position peaked at $5.08M in Q1 2024.
296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Weybosset Research & Management's 13F filing for Q2 2026, filed 28 Jul 2026.